GlassScriptPhysician profile
Behrooz Vaziri
NPI 1356736490
$2,209.86
in general payments reported to CMS, 2019-2025
12 companies · $85.23 in 2025
The $85.23 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.43 · 2021: $318 · 2022: $963 · 2023: $601 · 2024: $159 · 2025: $85.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $587.12 | 2019-2023 | Ekosonic |
| Sirtex Medical INC | $378.04 | 2021-2023 | Sir-Spheres Microspheres |
| Trisalus Life Sciences, INC. | $221.97 | 2022 | |
| Medtronic, INC. | $210.26 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Nuvasive, INC. | $196.45 | 2023 | Pulse |
| Balt USA, LLC | $173.00 | 2022-2025 | Prestige Coil System |
| Csl Behring | $158.54 | 2024 | Kcentra |
| Siemens Medical Solutions USA, INC. | $153.34 | 2022 | |
| Penumbra, INC. | $52.06 | 2022-2023 | Ruby Coil |
| Terumo Medical Corporation | $36.72 | 2025 | Tr Band |
| Angiodynamics, INC. | $25.81 | 2025 | Solero |
| Inari Medical, INC. | $16.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Behrooz Vaziri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.